Skip to content
AnthologyRX

CJC-1295 / Ipamorelin

A compounded CJC-1295 without DAC and ipamorelin prescription organized around upstream signaling, sleep rhythm, and recovery.

From $179/month

$537 billed every 3 months · 3-month commitment.
All fees included

Compounded by a licensed US pharmacy to an individual prescription. Compounded preparations are not FDA-approved drug products.

Questions before you start?

Compare this treatment

What will I pay?

Standard plan price$179 per month$537 every 3 months · 3-month commitment.

Billing options and renewal

The standard CJC-1295 / Ipamorelin price is $199 billed monthly, or $537 paid up front every three months ($179 per month equivalent; a three-month commitment). These are recurring prices before any eligible first-order discount. A first-order offer reduces that order only; renewal uses the standard price for the chosen plan. A monthly equivalent is not a monthly charge.

View full plan details

What should I know about this treatment?

A compounded CJC-1295 without DAC and ipamorelin prescription organized around upstream signaling, sleep rhythm, and recovery.

Explore this treatment in detail

What should I review before starting?

A licensed clinician reviews your health history and medications and determines whether treatment is appropriate for you.

Read the full Important Safety Information

What happens next?

Request one availability email. This does not subscribe you to marketing.

Notify me when available
What It Is

Two signaling pathways. One growth-hormone axis.

CJC-1295 without DAC and ipamorelin act on pathways involved in growth-hormone release. The CJC component works through growth hormone releasing hormone signaling; ipamorelin works through the growth hormone secretagogue receptor. The combination is not synthetic HGH.

The formulation matters when reading the research. This listing identifies CJC-1295 without DAC. Published human studies of long-acting CJC-1295 used a different, albumin-binding formulation; their duration of action and hormone measurements cannot establish the behavior of this preparation.

Long-acting CJC-1295 also preserved growth-hormone pulses in a human study, even while average and baseline hormone levels rose. Shorter duration should therefore not be presented as proof of more natural signaling or greater safety.3

If you are exploring this treatment for recovery or body composition, your consultation is the place to discuss your goals, medical history and monitoring. Changes in hormone levels alone do not establish improvements in sleep, tissue repair or performance.

  1. Ionescu M, Frohman LA. Pulsatile secretion of growth hormone (GH) persists during continuous… J Clin Endocrinol Metab. 2006. Human study of the long-acting formulation, not this compounded combination.PubMed
Who It's For

For the recovery question beneath the program.

01

The Slow-Recovery Athlete

Training and nutrition are already serious, but the space between hard sessions feels more expensive than it used to. You want the endocrine side evaluated rather than assuming more effort is the answer.

02

The GH-Axis Reader

You understand that stimulating upstream GH signaling is different from administering growth hormone directly. You want that distinction handled precisely, without the mythology around the category.

03

The Systems Thinker

You are interested in recovery as the interaction between training, sleep, nutrition, and endocrine signaling. A clinician-guided combination makes more sense to you than a research vial and a dosing forum.

Compounded CJC-1295 / Ipamorelin is not an FDA-approved drug product. Whether it is appropriate for you is determined by a licensed provider from your full Assessment.

This might not be the right fit if:
  • Active or suspected malignancy, or a history of cancer without oncology clearance
  • A history of pituitary disease or pituitary surgery, without clearance from the clinician managing it
  • Diabetes, prediabetes, or any medication that lowers blood sugar, without clearance from the clinician managing it
  • Competing in a tested sport, unless you have confirmed the position with your governing body
  • Pregnancy or breastfeeding
  • Known hypersensitivity to any component of the preparation
  • Under 18

Your intake screens for all contraindications. Every candidate is evaluated by a licensed clinician before any prescription is issued. No prescription is issued without clearance.

Your Plan

CJC-1295 / Ipamorelin, prescribed with care.

Compounded by a licensed 503A pharmacy. Prescribed by a licensed provider after clinical review.

Format
Injection
Strength
CJC-1295 1.2 mg, ipamorelin 2 mg per mL
Total plan quantity
15 mL
Billed amount
$537 every 3 months
Monthly figure
$179 per month
Commitment
3 months
Monthly option
$199 billed monthly · 5 mL total plan quantity
Fees
Included in the plan price

Strength describes the preparation. Total plan quantity is the amount included in that plan, not your dose or dosing schedule. Follow the directions on your prescription.

  • CJC-1295 confirmed without DAC, with short-acting rather than extended-half-life biology
  • Ipamorelin paired as a second upstream GH-secretagogue signal
  • Your clinician sets the dose and schedule for the individual prescription
  • Medical history, endocrine context, medications, and goals reviewed before treatment
  • Compounded to the individual prescription by a licensed US pharmacy if approved
Plan and billing details
$179/month on the quarterly plan, all-in. Consultation is included in the plan price, not added on top. Consultation, cancellation and refund policy.

Compounded by a licensed US pharmacy to an individual prescription. Compounded preparations are not FDA-approved drug products.

Have a question about this plan?

Billing

Our support team can help with plan prices, billing and portal access.

Ask about billing

Shipping

Contact AnthologyRX support for help checking a shipment.

Get shipment help

Clinical questions

Message your provider about dosing, side effects, your response or changes in your health.

Open patient portal

New to AnthologyRX? Ask our team about getting started.

The people behind your care

Guidance from the first question onward.

Independent clinical care

Licensed clinicians affiliated with AyaRx review your health history, medications and goals, then discuss whether CJC-1295 / Ipamorelin or another approach fits your needs.

Medical information on this page reviewed by Dr. Dylan Russell, MD, Chief Health Officer on . Your prescribing clinician provides your individual care.

Verify Dr. Russell's medical license

Pharmacy quality that matters

Prepared to your prescription by a licensed compounding pharmacy. Your prescription label identifies the dispensing pharmacy. Ask the pharmacist about preparation, storage and quality information for your medication.

Compounded preparations are not FDA-approved. Pharmacy quality controls and your clinician's evaluation of treatment evidence each have a role in your care.

Pharmacy & fulfillment

Your prescription label identifies the dispensing pharmacy. Contact our team for the pharmacy and state availability for your prescription.

Explore our pharmacy quality standards

A direct line for follow-up

Message your provider through the patient portal about dosing, side effects, your response or changes in your health. Contact AnthologyRX support for billing, shipment or portal-access help.

Important Safety Information

Commonly reported

  • Injection site reactions
  • Headache
  • Diarrhea
  • Flushing

The honest disclosure here is the size of the evidence base. Almost all published human data on CJC-1295 describes the long-acting DAC version rather than the short-acting molecule in this preparation; the reported effects are from those trials. Ipamorelin has one controlled human trial of any size, given intravenously to patients after bowel surgery, where adverse events were common in both the treated and placebo groups; there is no comparable dataset for subcutaneous use in healthy adults. Because both compounds push growth hormone release, your provider screens for active or recent cancer, asks about pituitary history, and reviews blood sugar and any diabetes medication given the ghrelin receptor involvement. Both compounds are prohibited at all times by the World Anti-Doping Agency, and human safety data for this combination is limited, which is the reason it sits with a clinician rather than in a shopping cart.

Questions

Asked and answered.

Explore

More in Performance & Recovery.

RECOVERY & REPAIR

BPC-157

From $179/mo
$537 billed every 3 months · 3-month commitment
Notify me when available

Expected Stock Date Early November

Learn more

Compounded BPC-157 sourced through a licensed US pharmacy and placed inside clinician review, not a research-vendor checkout.

ENERGY & RECOVERY

NAD+

From $159/mo
$477 billed every 3 months · 3-month commitment

Help boost energy, sharpen focus and support faster recovery with NAD+ injections at home.

CJC-1295 / IpamorelinFrom $179/month$537 billed every 3 months · 3-month commitment.
AnthologyRX
Find your treatment
Browse all treatments